chr18-22171677-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_005257.6(GATA6):c.533C>T(p.Ala178Val) variant causes a missense change. The variant allele was found at a frequency of 0.00014 in 1,499,588 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.00082 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000064 ( 2 hom. )
Consequence
GATA6
NM_005257.6 missense
NM_005257.6 missense
Scores
2
6
10
Clinical Significance
Conservation
PhyloP100: 4.73
Genes affected
GATA6 (HGNC:4174): (GATA binding protein 6) This gene is a member of a small family of zinc finger transcription factors that play an important role in the regulation of cellular differentiation and organogenesis during vertebrate development. This gene is expressed during early embryogenesis and localizes to endo- and mesodermally derived cells during later embryogenesis and thereby plays an important role in gut, lung, and heart development. Mutations in this gene are associated with several congenital defects. [provided by RefSeq, Mar 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0135444105).
BP6
Variant 18-22171677-C-T is Benign according to our data. Variant chr18-22171677-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 30209.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 124 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GATA6 | NM_005257.6 | c.533C>T | p.Ala178Val | missense_variant | 2/7 | ENST00000269216.10 | NP_005248.2 | |
GATA6 | XM_047437483.1 | c.533C>T | p.Ala178Val | missense_variant | 2/7 | XP_047293439.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GATA6 | ENST00000269216.10 | c.533C>T | p.Ala178Val | missense_variant | 2/7 | 1 | NM_005257.6 | ENSP00000269216.3 | ||
GATA6 | ENST00000581694.1 | c.533C>T | p.Ala178Val | missense_variant | 1/6 | 1 | ENSP00000462313.1 |
Frequencies
GnomAD3 genomes AF: 0.000821 AC: 124AN: 151060Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
124
AN:
151060
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000180 AC: 18AN: 100036Hom.: 3 AF XY: 0.000158 AC XY: 9AN XY: 56836
GnomAD3 exomes
AF:
AC:
18
AN:
100036
Hom.:
AF XY:
AC XY:
9
AN XY:
56836
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000638 AC: 86AN: 1348416Hom.: 2 Cov.: 30 AF XY: 0.0000645 AC XY: 43AN XY: 666200
GnomAD4 exome
AF:
AC:
86
AN:
1348416
Hom.:
Cov.:
30
AF XY:
AC XY:
43
AN XY:
666200
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000820 AC: 124AN: 151172Hom.: 0 Cov.: 32 AF XY: 0.000663 AC XY: 49AN XY: 73862
GnomAD4 genome
AF:
AC:
124
AN:
151172
Hom.:
Cov.:
32
AF XY:
AC XY:
49
AN XY:
73862
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
17
ClinVar
Significance: Benign/Likely benign
Submissions summary: Pathogenic:1Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Atrioventricular septal defect 5 Pathogenic:1Benign:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Oct 01, 2010 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 21, 2024 | - - |
Monogenic diabetes Benign:1
Benign, criteria provided, single submitter | research | Personalized Diabetes Medicine Program, University of Maryland School of Medicine | Jan 26, 2018 | ACMG criteria: PP3 (6 predictors), BP4 (4 predictors), BS1 (1.01% in ExAC African pop.), BS2 (2 homozyotes and 34 hets for dominant condition)=benign - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Jan 20, 2021 | This variant is associated with the following publications: (PMID: 20581743) - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Pathogenic
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Uncertain
D;D
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
D
LIST_S2
Benign
.;T
MetaRNN
Benign
T;T
MetaSVM
Uncertain
D
MutationAssessor
Benign
L;L
PrimateAI
Pathogenic
D
PROVEAN
Benign
N;.
REVEL
Uncertain
Sift
Uncertain
D;.
Sift4G
Uncertain
D;D
Polyphen
D;D
Vest4
MutPred
Gain of catalytic residue at A178 (P = 0.0275);Gain of catalytic residue at A178 (P = 0.0275);
MVP
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at